$2.54T
Total marketcap
$78.67B
Total volume
BTC 51.58%     ETH 14.64%
Dominance

ResMed Inc. RMD.XA Stock

32.84 AUD {{ price }} -0.763066% {{change_pct}}%
COUNTRY
Australia
Exchange
Cboe AU
Market Cap
0 AUD
LOW - HIGH [24H]
32.77 - 33.07 AUD
VOLUME [24H]
531.23K AUD
{{ volume }}
P/E Ratio
17.25
Earnings per share
1.9 AUD

ResMed Inc. Price Chart

ResMed Inc. RMD.XA Financial and Trading Overview

ResMed Inc. stock price 32.84 AUD
Previous Close 31.85 AUD
Open 31.75 AUD
Bid 0 AUD x N/A
Ask 0 AUD x N/A
Day's Range 31.71 - 31.97 AUD
52 Week Range 27.85 - 36.33 AUD
Volume 107.41K AUD
Avg. Volume 151.33K AUD
Market Cap N/A
Beta (5Y Monthly) 0.480633
PE Ratio (TTM) 16.68693
EPS (TTM) 1.9 AUD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

RMD.XA Valuation Measures

Enterprise Value 20.2B AUD
Trailing P/E 16.68693
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 4.74623
Enterprise Value/Revenue 5.031
Enterprise Value/EBITDA 16.116

Trading Information

ResMed Inc. Stock Price History

Beta (5Y Monthly) 0.480633
52-Week Change 11.75%
S&P500 52-Week Change 20.43%
52 Week High 36.33 AUD
52 Week Low 27.85 AUD
50-Day Moving Average 33.62 AUD
200-Day Moving Average 32.94 AUD

RMD.XA Share Statistics

Avg. Volume (3 month) 151.33K AUD
Avg. Daily Volume (10-Days) 158.95K AUD
Shares Outstanding N/A
Float 582.27M
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 7.55%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 1.74
Trailing Annual Dividend Yield 5.46%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends June 30, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End June 30, 2023

Profitability

Profit Margin 21.49%
Operating Margin (ttm) 27.92%
Gross Margin 57.00%
EBITDA Margin 31.21%

Management Effectiveness

Return on Assets (ttm) 12.06%
Return on Equity (ttm) 23.93%

Income Statement

Revenue (ttm) 4.02B AUD
Revenue Per Share (ttm) 6.85 AUD
Quarterly Revenue Growth (yoy) 29.19%
Gross Profit (ttm) 2.06B AUD
EBITDA 1.25B AUD
Net Income Avi to Common (ttm) 862.95M AUD
Diluted EPS (ttm) 1.90325
Quarterly Earnings Growth (yoy) 29.89%

Balance Sheet

Total Cash (mrq) 240.01M AUD
Total Cash Per Share (mrq) 0.41 AUD
Total Debt (mrq) 1.72B AUD
Total Debt/Equity (mrq) 43.84 AUD
Current Ratio (mrq) 3.069
Book Value Per Share (mrq) 6.6915

Cash Flow Statement

Operating Cash Flow (ttm) 535.35M AUD
Levered Free Cash Flow (ttm) 288.28M AUD

Profile of ResMed Inc.

Country Australia
State CA
City San Diego
Address 9001 Spectrum Center Boulevard
ZIP 92123
Phone 858 836 5000
Website https://www.resmed.com
Industry
Sector(s)
Full Time Employees 8160

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Q&A For ResMed Inc. Stock

What is a current RMD.XA stock price?

ResMed Inc. RMD.XA stock price today per share is 32.84 AUD.

How to purchase ResMed Inc. stock?

You can buy RMD.XA shares on the Cboe AU exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for ResMed Inc.?

The stock symbol or ticker of ResMed Inc. is RMD.XA.

How many shares does ResMed Inc. have in circulation?

The max supply of ResMed Inc. shares is 0.

What is ResMed Inc. Price to Earnings Ratio (PE Ratio)?

ResMed Inc. PE Ratio is 17.25338400 now.

What was ResMed Inc. earnings per share over the trailing 12 months (TTM)?

ResMed Inc. EPS is 1.9 AUD over the trailing 12 months.

Stocks Related By Sector

Stocks Related By Industry

Stocks Related By Marketcap